Our Goals

Double survival

Halve the Average Years of Life Lost (AYLL) to a brain tumour by 2025

This is a challenging measure to change as improvements take time to be reflected

How did we do?

One-year survival has improved significantly in recent years which gives us hope that progress is being made

One thing that’s amazing about The Charity, is that it’s constantly punching above its weight. It’s constantly looking for those new ideas and new approaches, not as a gimmick but as something that will change the field forever.

Richard Gilbertson, Li Ka-shing Chair of Oncology, Head of Dept. of Oncology and Director of the Cambridge Cancer Centre at Cambridge University, as well as the Chair of The Charity’s Biomedical Scientific Advisory Board and the Tessa Jowell Brain Cancer Mission

Halve the harm

Halve the harm that brain tumours have on quality of life by 2020

How did we do?

Unfortunately, COVID-19 has delayed the ability to gather 2020 data to measure improvements to this

In the future, we will use BRIAN – our pioneering databank and app – to develop a measuring tool, and to monitor health-related quality of life.

A Cure Can't Wait

*Based on data for three years prior, due to the collection lag. †High grade tumours only; low grade data are unavailable. 1Global Burden of Disease (2017). (Accessed September 2019). 2Most recent data available from devolved nation statistical websites, June 2020. 3‘Life with a brain tumour’ research, Alterline, 2015.